1-160084088-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004983.3(KCNJ9):c.58G>A(p.Gly20Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000221 in 1,539,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G20A) has been classified as Uncertain significance.
Frequency
Consequence
NM_004983.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ9 | NM_004983.3 | c.58G>A | p.Gly20Ser | missense_variant | 2/3 | ENST00000368088.4 | NP_004974.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ9 | ENST00000368088.4 | c.58G>A | p.Gly20Ser | missense_variant | 2/3 | 1 | NM_004983.3 | ENSP00000357067.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151940Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000210 AC: 3AN: 142888Hom.: 0 AF XY: 0.0000391 AC XY: 3AN XY: 76770
GnomAD4 exome AF: 0.0000216 AC: 30AN: 1387668Hom.: 0 Cov.: 32 AF XY: 0.0000205 AC XY: 14AN XY: 684566
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151940Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74224
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.58G>A (p.G20S) alteration is located in exon 2 (coding exon 1) of the KCNJ9 gene. This alteration results from a G to A substitution at nucleotide position 58, causing the glycine (G) at amino acid position 20 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at